H. Lundbeck A/S (CPH:HLUN.B)
42.86
-1.94 (-4.33%)
At close: Jun 8, 2026
H. Lundbeck Revenue
H. Lundbeck had revenue of 7.13B DKK in the quarter ending March 31, 2026, with 14.27% growth. This brings the company's revenue in the last twelve months to 25.52B, up 11.19% year-over-year. In the year 2025, H. Lundbeck had annual revenue of 24.63B with 11.93% growth.
Revenue (ttm)
25.52B
Revenue Growth
+11.19%
P/S Ratio
1.68
Revenue / Employee
5.10M
Employees
5,000
Market Cap
42.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 24.63B | 2.63B | 11.93% |
| Dec 31, 2024 | 22.00B | 2.09B | 10.51% |
| Dec 31, 2023 | 19.91B | 1.67B | 9.13% |
| Dec 31, 2022 | 18.25B | 1.95B | 11.95% |
| Dec 31, 2021 | 16.30B | -1.37B | -7.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 327.80B |
| Coloplast | 28.05B |
| Genmab | 25.29B |
| Demant | 22.97B |
| GN Store Nord | 16.60B |
| Zealand Pharma | 9.24B |
| ALK-Abelló | 6.56B |
| Embla Medical | 6.21B |
H. Lundbeck News
- 3 days ago - H. Lundbeck Transcript: Study update - Transcripts
- 3 days ago - H. Lundbeck Press release: Study update - Filings
- 3 days ago - H. Lundbeck Slides: Study update - Filings
- 3 days ago - Lundbeck's experimental drug cuts migraine days in mid-stage trial - Reuters
- 26 days ago - H. Lundbeck Quarterly report: Q1 2026 - Filings
- 26 days ago - H. Lundbeck Slides: Q1 2026 - Filings
- 26 days ago - H. Lundbeck Earnings Call Transcript: Q1 2026 - Transcripts
- 26 days ago - H. Lundbeck Quarterly report: Q1 2026 - Filings